Concepedia

Michael Chaloupka

MC

Statistics

Publications

20

Citations

561

H-Index

15

Active since

2014

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

Center for Integrated Protein Science Munich

German Center for Lung Research

University Hospital Cologne

Michael Chaloupka is an author at Ludwig-Maximilians-Universität München specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

2014–2025

20

Publications

20

Impact of a New Fusion Receptor on PD-1–Mediated Immunosuppression in Adoptive T Cell Therapy

Sebastian Kobold, Simon Grassmann, Michael Chaloupka et al. · JNCI Journal of the National Cancer Institute · 2015 · 125 citations · Full text

, , +17

Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45

Michael Pritsch, Najib Ben-Khaled, Michael Chaloupka et al. · Journal of Immunology Research · 2016 · 56 citations · Full text

, , +17

Selective Bispecific T Cell Recruiting Antibody and Antitumor Activity of Adoptive T Cell Transfer

Sebastian Kobold, Julius Steffen, Michael Chaloupka et al. · JNCI Journal of the National Cancer Institute · 2014 · 42 citations · Full text

, , +17

Evolution of Robotic Urology in Clinical Practice from the Beginning to Now: Results from the GRAND Study Register

Nikolaos Pyrgidis, Yannic Volz, Benedikt Ebner et al. · European Urology Focus · 2024 · 32 citations · Full text

, , +10

Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion

Maria Apfelbeck, Michael Chaloupka, Boris Schlenker et al. · Clinical Hemorheology and Microcirculation · 2019 · 31 citations

, , +17

1–5 of 20